Elox ticker
WebFind the latest Eloxx Pharmaceuticals, Inc. (ELOX) stock quote, history, news and other vital information to help you with your stock trading and investing. Web(NASDAQ: ELOX) Eloxx Pharmaceuticals's current Earnings Per Share (EPS) is -$17.60. On average, analysts forecast that ELOX's EPS will be -$0.50 for 2024, with the lowest EPS forecast at -$0.53, and the highest EPS forecast at -$0.46.
Elox ticker
Did you know?
WebMorgan Stanley Analyst Reiterates Buy Rating on Delta Air Lines, DAL. Apr 10, 2024. Our scanners at IndustrialStockMovers.com, with the help of Tipranks.com, found the following stock... WebDec 23, 2024 · Stock Evaluator: Eloxx Pharmaceuticals Inc (ELOX) + Follow This Stock $2.04 -0.09 -4.23% December 23, 2024 3:42:33 PM EST Volume: 13,024 USD NASD DELAYED PRICE News & Events A+ Stock Grade Summary: COMPANY SUMMARY Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.
WebThe ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the … WebEloxx Pharmaceuticals Inc (ELOX) Dividend News Alerts. ELOX Stock Quote and Dividend Data ELOX Dividend History Detail ELOX Projected 10 Year Dividend Yield ELOX …
WebEloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. The … WebEloxx Pharmaceuticals Inc. analyst estimates, including ELOX earnings per share estimates and analyst recommendations.
WebPontifax Management 4 G.p. (2015) Ltd. Net Worth 2024 and insider trades. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening.
WebOct 28, 2007 · The Company’s product candidates are derived from multiple key proprietary technology platforms: cell-based arrayed antibody discovery, ultralong antibody scaffolds … dogezilla tokenomicsWebApr 12, 2024 · How much insider buying is happening at Eloxx Pharmaceuticals? Insiders have purchased a total of 8,442,591 ELOX shares in the last 24 months for a total of $11,365,997.85 bought. This page (NASDAQ:ELOX) was last updated on 4/7/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free. Sign up for … dog face kaomojiWebApr 10, 2024 · NASDAQ - Stock Price Chart. S&P 500 - Stock Price Chart. 4371 Advancing. Declining 3643. 52.8%. 44.0%. 63 New High. New Low 169. doget sinja goricaWebApr 7, 2024 · Eloxx Pharmaceuticals Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-8.260 per share for the current fiscal year. Eloxx Pharmaceuticals Inc does not currently pay a dividend. The Biotechnology and Medical … dog face on pj'sWebELOX is currently covered by 4 analysts with an average potential upside of $74.73 (324.6%) backed by displayed 9 price targets and 19 ratings. Analysts average stock forecasts to be materialized ratio is 15% with an average time for these price targets to be met of 57.67 days. dog face emoji pngWebStocks & ETFs, MFs, Crypto & FOREX. AI Pattern Search Engine. Stocks & ETFs, Crypto & FOREX dog face makeupWebApr 8, 2024 · Saturday, April 08, 2024 3:00:48 PM Post # of 586697 ELOX: However, Dude, my 'Broker' said the following to me about ELOX, for Monday. (See his succinct admonition to me, below.) (That's ME ---... dog face jedi